Jergon Sacha (Dracontium peruviuanum) — Hermetica Encyclopedia
Herbs (Global Traditional) · Amazonian

Jergon Sacha (Dracontium peruviuanum) (Dracontium peruviuanum)

Moderate Evidencebotanical2 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

Jergon Sacha (Dracontium peruvianum) is an Amazonian plant containing oxylipins that demonstrate immunostimulant effects in preclinical studies. The plant's bioactive compounds work by modulating immune system responses and neutralizing certain snake venom components through anti-coagulant mechanisms.

2
PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerbs (Global Traditional)
GroupAmazonian
Evidence LevelModerate
Primary KeywordJergon Sacha benefits
Synergy Pairings3
Jergon Sacha close-up macro showing natural texture and detail — rich in antiviral, antimicrobial, immunomodulatory
Jergon Sacha (Dracontium peruviuanum) — botanical close-up

Health Benefits

Origin & History

Jergon Sacha growing in Amazon — natural habitat
Natural habitat

Jergon Sacha is a tropical herb from the Araceae family, primarily sourced from the Amazon rainforest in Peru and Colombia, with the plant species identified as Dracontium loretense (also referred to as Dracontium peruvianum or Dracontium longipes). It is typically extracted as a concentrated liquid extract (1:4 ratio) from the rhizome or root using water or alcohol-based methods common in traditional herbal processing.

In Amazonian traditional medicine systems of Peru and Colombia, Jergon Sacha has been used by indigenous healers for centuries to treat wounds, rheumatism, arthritis, snakebites, skin problems, and as an antiviral/immunostimulant. It mimics the morphology of medicinal plants like Jergon de Pico to aid identification in herbalism, with historical use documented in rainforest ethnobotany.Traditional Medicine

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on Jergon Sacha. Research is limited to preclinical studies including in vitro profiling of ceramides/cerebrosides (Napolitano et al., 2011), oxylipins with immunostimulant effects (Benavides et al., 2009; J Nat Prod 72(5):813-7), and antivenin neutralization in animal models (Nunez et al., 2004; Braz J Med Biol Res 37(7):969-77).

Preparation & Dosage

Jergon Sacha prepared as liquid extract — pairs with Cat's Claw, Pau d'Arco, Astragalus
Traditional preparation

Traditional suggested use is 2 ml of 1:4 concentrated liquid extract, taken 2 or more times daily. No clinically studied dosages are available due to the absence of human trials. No standardization to specific compounds is specified. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 2.5g per 100g", "fiber": "Approximately 3.0g per 100g"}, "micronutrients": {"vitamin_C": "Approximately 12mg per 100g", "calcium": "Approximately 40mg per 100g", "iron": "Approximately 1.2mg per 100g"}, "bioactive_compounds": {"oxylipins": "Concentration not specified, known for immunostimulant effects", "ceramides": "Concentration not specified, profiled for antiviral properties", "cerebrosides": "Concentration not specified, profiled for antiviral properties"}, "bioavailability_notes": "The bioavailability of these compounds can vary based on preparation methods and individual metabolism. The presence of oxylipins, ceramides, and cerebrosides suggests potential health benefits, but specific absorption rates are not well-documented."}

How It Works

Mechanism of Action

Jergon Sacha's oxylipins modulate immune system function by stimulating immunocompetent cells and enhancing cytokine production pathways. The plant's bioactive compounds neutralize snake venom effects by inhibiting phospholipase A2 enzymes and blocking coagulation cascades. These mechanisms involve direct binding to venom proteins and competitive inhibition of inflammatory mediators.

Clinical Evidence

Evidence for Jergon Sacha comes primarily from animal studies rather than human clinical trials. Benavides et al. (2009) demonstrated immunostimulant effects in preclinical models, while Nunez et al. (2004) showed neutralization of Bothrops asper venom edema and coagulant effects in laboratory animals. No large-scale human studies have been conducted to establish clinical efficacy or optimal dosing protocols. The current evidence base is limited to traditional use reports and preliminary laboratory research.

Safety & Interactions

Safety data for Jergon Sacha in humans is extremely limited due to lack of clinical trials. Traditional use suggests general tolerability, but specific side effects, optimal dosages, and contraindications remain undefined. No documented drug interactions exist in scientific literature, though caution is advised with anticoagulant medications due to potential additive effects. Pregnancy and breastfeeding safety has not been established, and use should be avoided during these periods.

Synergy Stack

Hermetica Formulation Heuristic

Frequently Asked Questions

What compounds in Jergon Sacha provide immune support?
Jergon Sacha contains oxylipins, which are bioactive lipid compounds that demonstrate immunostimulant effects in laboratory studies. These compounds work by modulating immune cell activity and enhancing cytokine production pathways.
How does Jergon Sacha neutralize snake venom?
Jergon Sacha neutralizes snake venom by inhibiting phospholipase A2 enzymes and blocking coagulation cascades. Studies show it effectively reduces Bothrops asper venom edema and coagulant effects through competitive inhibition of venom proteins.
What is the recommended dosage for Jergon Sacha supplements?
No standardized dosage for Jergon Sacha supplements has been established through clinical trials. Traditional preparations vary widely, and without human safety studies, optimal dosing protocols remain undefined.
Are there any side effects from taking Jergon Sacha?
Specific side effects of Jergon Sacha have not been documented in scientific literature due to limited human studies. Traditional use suggests general tolerability, but comprehensive safety profiles have not been established through controlled research.
Can Jergon Sacha interact with blood thinning medications?
While no documented interactions exist in literature, theoretical concerns exist with anticoagulant medications due to Jergon Sacha's anti-coagulant properties shown in snake venom studies. Consultation with healthcare providers is recommended before combining with blood thinners.
Is Jergon Sacha safe to take during pregnancy or while breastfeeding?
There is insufficient clinical data on the safety of Jergon Sacha during pregnancy and breastfeeding, so it is not recommended for these populations without medical supervision. Traditional use in Peru does not establish safety in these sensitive periods, and the oxylipins and other bioactive compounds have not been adequately studied in pregnant or nursing women. Consult with a healthcare provider before using Jergon Sacha if you are pregnant, planning to conceive, or breastfeeding.
What is the difference between Jergon Sacha root extract and whole plant preparations?
Root extracts typically concentrate specific bioactive compounds like oxylipins and ceramides through processing, potentially offering higher potency per dose, while whole plant preparations preserve the full spectrum of plant constituents as they exist in traditional use. Extract forms may provide faster bioavailability and standardized dosing, but whole plant preparations may offer synergistic effects from multiple compounds working together. The most effective form depends on the intended use—extracts are typically preferred for immune support, while traditional whole plant preparations maintain cultural and historical preparation methods.
What does current research show about Jergon Sacha's antiviral potential?
Preliminary phytochemical analysis has identified ceramides and cerebrosides in Jergon Sacha that possess theoretical antiviral properties based on laboratory profiling (Napolitano et al., 2011), but human clinical trials demonstrating efficacy against specific viruses have not yet been conducted. Most evidence remains at the preclinical level, meaning compounds show promise in test tubes or animal models but lack human validation. More rigorous clinical research is needed to determine whether Jergon Sacha can be reliably used as an antiviral support supplement.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.